Proteinuria selectivity and prednisone response in children with nephrotic syndrome

Gustavo Pérez-Cortés1, J Jesús Pérez-Molina2, Cristina Ochoa-Ponce1

  • 1Nuevo Hospital Civil de Guadalajara "Dr. Juan I. Menchaca", División de Pediatría, Servicio de Nefrología Pediátrica.

Insights

The proteinuria selectivity index (PSI) predicts prednisone response in primary nephrotic syndrome (PNS). A PSI ≥ 0.20 indicates poor response, while PSI ≤ 0.10 suggests satisfactory outcomes in pediatric patients.

Area of Science:

  • Nephrology
  • Pediatric Nephrology
  • Clinical Medicine

Background:

  • Primary nephrotic syndrome (PNS) is a common kidney disorder in children.
  • Predicting treatment response is crucial for managing PNS.
  • The proteinuria selectivity index (PSI) has shown potential in predicting prednisone responsiveness.

Purpose of the Study:

  • To investigate the association between the proteinuria selectivity index (PSI) and prednisone response in pediatric patients with PNS.
  • To determine if PSI can serve as a reliable biomarker for predicting treatment outcomes in PNS.

Main Methods:

  • An analytical cross-sectional study was conducted with pediatric patients diagnosed with PNS.
  • Patients were categorized into groups with good or poor response to prednisone based on relapse frequency.
  • PSI was calculated using serum and urinary measurements of IgG and transferrin, with statistical analysis including Chi square and Odds Ratio (OR).

Main Results:

  • Out of 67 patients, 49.3% showed a good response and 50.7% a poor response to prednisone.
  • A PSI ≥ 0.20 mg/mg was significantly associated with a poor response to prednisone (67.6% of poor responders vs. 18.2% of good responders, p < 0.001).
  • A PSI ≤ 0.10 mg/mg was more common in patients with a good response to prednisone (60.6% vs. 8.8%, p < 0.001).

Conclusions:

  • In pediatric patients with PNS, a high PSI (≥ 0.20 mg/mg) is indicative of a poor response to prednisone.
  • Conversely, a low PSI (≤ 0.10 mg/mg) is associated with a satisfactory response to prednisone treatment.
  • PSI is a valuable tool for predicting prednisone treatment outcomes in children with primary nephrotic syndrome.
Abstract

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
52
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
231
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
96
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
59
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
168
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
235